Forests and Related Resources
ID: 8.1Type: Phase II
Overview

Topic

Forests and Related Resources

Agency

Department of AgricultureNational Institute of Food and Agriculture

Program

Type: BOTHPhase: Phase IIYear: 2024
Timeline
    Description

    The Department of Agriculture's National Institute of Food and Agriculture is seeking proposals for the Small Business Innovation Research and Small Business Technology Transfer Programs Phase II. The specific topic of the solicitation is "Forests and Related Resources" (Topic Number 8.1).

    The goal of this topic is to address the health, diversity, and productivity of the nation's forests. The research aims to develop environmentally sound approaches to increase productivity of forest lands, improve sustainability, and develop value-added materials derived from forest resources.

    The solicitation is open for Phase II projects and the project duration is not specified. The funding specifics can be found on the USDA-NIFA website. The application due date for this solicitation is March 26, 2024.

    For more information and to access the solicitation, please visit the USDA-NIFA SBIR website.

    Files
    No associated files provided.
    Similar Opportunities
    NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
    NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required). This solicitation aims to support Small Business Concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require Federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, safety monitoring, and regulatory activities. The project duration is not specified, but the application due dates are provided. More information can be found on the grants.gov website.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Technology Transfer (STTR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and genetic analysis tools. The solicitation is open until September 6, 2025, and multiple application due dates are provided. For more information and to apply, visit the SBIR topic link here and the solicitation agency URL here.
    DOD SBIR 24.4 Annual - xTech Search 8 SBIR Finalist Open Topic Competition
    Active
    Department of Defense
    The Department of Defense (DOD) is seeking proposals for the xTech Search 8 SBIR Finalist Open Topic Competition. The objective of this solicitation is to find novel and disruptive concepts and technology solutions with dual-use capabilities that can address the Army's current needs and apply to current Army concepts. The technology areas of interest include Electronics, Human Systems, and Sensors. The Army is particularly interested in technologies related to Artificial Intelligence/Machine Learning, Advanced Materials, Advanced Manufacturing, Autonomy, Cyber, Human Performance, Immersive, Network Technologies, Position, Navigation and Timing (PNT), Power, Software Modernization, and Sensors. The Phase I of the project requires a feasibility study and concept plans, while Phase II involves producing prototype solutions for evaluation by soldiers. Phase III focuses on the maturation of the technology and commercialization. The solicitation is open until March 31, 2025. For more information, visit the solicitation agency website.
    DOD SBIR 24.4 Annual - xTech Search 8 SBIR Finalist Open Topic Competition
    Active
    Department of Defense
    The Department of Defense (DOD) is seeking proposals for the xTech Search 8 SBIR Finalist Open Topic Competition. The objective of this solicitation is to find novel and disruptive concepts and technology solutions with dual-use capabilities that can address the Army's current needs and apply to current Army concepts. The technology areas of interest include Electronics, Human Systems, and Sensors. The Army is particularly interested in technologies related to Artificial Intelligence/Machine Learning, Advanced Materials, Advanced Manufacturing, Autonomy, Cyber, Human Performance, Immersive, Network Technologies, Position, Navigation and Timing (PNT), Power, Software Modernization, and Sensors. The Phase I of the project requires a feasibility study and concept plans, while Phase II involves producing prototype solutions that can be easily operated by soldiers. Phase III focuses on the maturation of the technology and its transition to TRL 6/7, as well as further development and commercialization. The solicitation is open until March 31, 2025. For more information, visit the solicitation agency website.
    DOD SBIR 24.4 Annual - xTechSpecial Forces
    Active
    Department of Defense
    The Department of Defense (DOD) is seeking proposals for the SBIR 24.4 Annual solicitation. The specific topic of the solicitation is "xTechSpecial Forces" and it is being conducted by the Army branch. The solicitation is open until March 31, 2025. The first topic of the solicitation is "GPS Denied ATAK Compatible Self Location Application." The US Army 1st Special Forces Command (Airborne) is looking for a software solution that can obtain self-location data in GPS-denied situations and integrate it into the Android Team Awareness Kit (ATAK) software platform. The software should enable self-location without the use of GPS, other networks, or additional hardware. The goal is to allow ground operators to take a picture of the sky to obtain images including celestial objects and/or passing satellites, resulting in operationally suitable self-location. The second topic is "SWARM Tracker – Counter UxS Warning System." The Army Special Operations Command is seeking an automated tool that can provide early warning of swarmed sensors and effects similar to the National Weather System's severe weather warning systems. The tool should integrate with existing and emerging systems, provide multi-modal awareness, and deliver timely notifications to tactical units and base defense operating centers. The focus is on reducing cognitive load and building user-centric notification systems. The third topic is "PSYOP Product Air Delivery Vehicle." The Army Special Operations Command requires a self-guided aerial delivery system for disseminating Psychological Operations products. The Air Delivery Vehicle (ADV) should be interchangeable depending on payload and mission requirements, resistant to electronic attack, and capable of accommodating payloads ranging from 8 ounces to 50 pounds. The ADV should have self-navigation capabilities, accurate release points, and the ability to operate in day and night conditions. The fourth topic is "Non-Attributable Mobile Mesh Network Radio." The 1st Special Forces Command is interested in a small form factor, non-attributable mesh network radio system for position location information (PLI), voice, sensor integration, and data transmission. The system should enable continuous communication outside of cellular/internet coverage, have a low physical and RF signature, and integrate with the Android Team Awareness Kit (ATAK). The fifth topic is "Distributed Electromagnetic Sensing, Automated Characterization, and Simple Reporting systems." The 1st Special Forces Command is interested in technological solutions to enhance Electronic Warfare (EW) capabilities. The focus is on scalable, cost-effective, software-based innovations that address core need areas such as AI/ML-enabled edge processing, automated signal detection and characterization, near-real-time data availability, and integration with tactical situational awareness systems. The Phase I proposals for this solicitation can receive funding up to $250,000 for a 6-month period, while Direct to Phase II proposals can receive funding up to $2,000,000 for an 18-month period. Phase I involves completing a feasibility study and developing concept plans, while Phase II focuses on producing prototype solutions. Phase III involves maturing the technology to TRL 6/7, producing prototypes for further evaluation, and updating prototypes based on soldier feedback. For more information and to submit a proposal, visit the solicitation agency's website: [link](https://www
    Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Innovation Research (SBIR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and tools for monitoring cognitive function. The solicitation is open until September 8, 2025, with multiple application due dates throughout the year. More information can be found on the grants.gov website.